Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOST-ASSURE: Promus Element vs. Endeavor Resolute and TAT vs. DDAT in CHD
NCT01267734Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol, clopidogrel in coronary heart disease (CHD), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
cilostazolclopidogrel
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT01267734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01267734.